Proteomics

Dataset Information

0

Native SEC-MS of the human HT29 colon adenocarcinoma cell line treated with the HSP90 inhibitor tanespimycin (17-AAG)


ABSTRACT: The molecular chaperone heat shock protein 90 (HSP90) works in concert with its co-chaperones to stabilize its client proteins, which include several drivers of oncogenesis and malignant progression. Pharmacologic inhibitors of HSP90 are proposed to trigger widespread remodeling of cellular protein complexes, including dissociation of co-chaperones from HSP90, disruption of client protein signaling networks, and recruitment of the protein ubiquitination and degradation machinery. However, proteomic studies to date have focused on inhibitor-induced changes in total protein levels, often overlooking protein complex alterations. Here, we use size-exclusion chromatography in combination with mass spectrometry (SEC-MS) to characterize the changes in native protein complexes following treatment with the HSP90 inhibitor 17-AAG in the human HT29 colon adenocarcinoma cell line.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture, Colon

DISEASE(S): Colon Cancer

SUBMITTER: Rahul Samant  

LAB HEAD: Rahul S. Samant

PROVIDER: PXD033459 | Pride | 2022-12-20

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
PT4508-100.raw Raw
PT4508-101.raw Raw
PT4508-102.raw Raw
PT4508-103.raw Raw
PT4508-104.raw Raw
Items per page:
1 - 5 of 380

Similar Datasets

2023-05-22 | GSE218190 | GEO
2023-05-30 | PXD030486 | Pride
| PRJNA221226 | ENA
2019-11-08 | GSE126151 | GEO
2009-06-08 | E-GEOD-12287 | biostudies-arrayexpress
2023-08-10 | PXD040875 | Pride
2021-04-23 | PXD022708 | Pride
2019-01-31 | PXD012229 | Pride
2009-05-27 | GSE12287 | GEO
2023-03-11 | PXD033678 | Pride